Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Rheological characterization of dynamic remodeling of the pericellular region by human mesenchymal stem cell-secreted enzymes in well-defined synthetic hydrogel scaffolds.

Daviran M, Longwill SM, Casella JF, Schultz KM.

Soft Matter. 2018 Apr 25;14(16):3078-3089. doi: 10.1039/c8sm00408k.

PMID:
29667686
2.

Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes.

Jordan LC, Roberts Williams DO, Rodeghier MJ, Covert Greene BV, Ponisio MR, Casella JF, McKinstry RC, Noetzel MJ, Kirkham FJ, Meier ER, Fuh B, McNaull M, Sarnaik S, Majumdar S, McCavit TL, DeBaun MR.

Am J Hematol. 2018 Jun;93(6):760-768. doi: 10.1002/ajh.25085. Epub 2018 Mar 30.

PMID:
29520844
3.

Diagnostic utility of telomere length testing in a hospital-based setting.

Alder JK, Hanumanthu VS, Strong MA, DeZern AE, Stanley SE, Takemoto CM, Danilova L, Applegate CD, Bolton SG, Mohr DW, Brodsky RA, Casella JF, Greider CW, Jackson JB, Armanios M.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2358-E2365. doi: 10.1073/pnas.1720427115. Epub 2018 Feb 20. Erratum in: Proc Natl Acad Sci U S A. 2018 Apr 23;:.

4.

Identification of Aptamers That Bind to Sickle Hemoglobin and Inhibit Its Polymerization.

Purvis SH, Keefer JR, Fortenberry YM, Barron-Casella EA, Casella JF.

Nucleic Acid Ther. 2017 Dec;27(6):354-364. doi: 10.1089/nat.2016.0646. Epub 2017 Oct 17.

PMID:
29039727
5.

Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia.

Chaturvedi S, Bhatnagar P, Bean CJ, Steinberg MH, Milton JN, Casella JF, Barron-Casella E, Arking DE, DeBaun MR.

Blood. 2017 Aug 3;130(5):686-688. doi: 10.1182/blood-2017-02-769661. Epub 2017 Jun 5. No abstract available.

PMID:
28584135
6.

High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Gamper CJ, Takemoto CM, Chen AR, Symons HJ, Loeb DM, Casella JF, Dezern AE, King KE, McGonigle AM, Jones RJ, Brodsky RA.

J Pediatr Hematol Oncol. 2016 Nov;38(8):627-635.

7.

Widespread Pain Among Youth With Sickle Cell Disease Hospitalized With Vasoocclusive Pain: A Different Clinical Phenotype?

Zempsky WT, Wakefield EO, Santanelli JP, New T, Smith-Whitley K, Casella JF, Palermo TM.

Clin J Pain. 2017 Apr;33(4):335-339. doi: 10.1097/AJP.0000000000000403.

PMID:
27322398
8.

Newborn Screening Programs and Sickle Cell Disease: A Public Health Services and Systems Approach.

Minkovitz CS, Grason H, Ruderman M, Casella JF.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S39-47. doi: 10.1016/j.amepre.2016.02.019.

9.

Stereotyped spatial patterns of functional synaptic connectivity in the cerebellar cortex.

Valera AM, Binda F, Pawlowski SA, Dupont JL, Casella JF, Rothstein JD, Poulain B, Isope P.

Elife. 2016 Mar 16;5. pii: e09862. doi: 10.7554/eLife.09862.

10.

Preventive Care Delivery to Young Children With Sickle Cell Disease.

Bundy DG, Muschelli J, Clemens GD, Strouse JJ, Thompson RE, Casella JF, Miller MR.

J Pediatr Hematol Oncol. 2016 May;38(4):294-300. doi: 10.1097/MPH.0000000000000537.

11.

Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease.

Lance EI, Comi AM, Johnston MV, Casella JF, Shapiro BK.

Clin Pediatr (Phila). 2015 Oct;54(11):1087-93. doi: 10.1177/0009922815594356. Epub 2015 Jul 6.

12.

Transcranial Doppler screening of Medicaid-insured children with sickle cell disease.

Bundy DG, Abrams MT, Strouse JJ, Mueller CH, Miller MR, Casella JF.

J Pediatr. 2015 Jan;166(1):188-90. doi: 10.1016/j.jpeds.2014.09.018. Epub 2014 Oct 14.

PMID:
25444529
13.

Transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Casella JF.

N Engl J Med. 2014 Nov 6;371(19):1841-2. doi: 10.1056/NEJMc1411133. No abstract available.

14.

Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Lance EI, Casella JF, Everett AD, Barron-Casella E.

Proteomics Clin Appl. 2014 Dec;8(11-12):813-27. doi: 10.1002/prca.201400069. Epub 2014 Nov 6. Review.

15.

Immunologic effects of hydroxyurea in sickle cell anemia.

Lederman HM, Connolly MA, Kalpatthi R, Ware RE, Wang WC, Luchtman-Jones L, Waclawiw M, Goldsmith JC, Swift A, Casella JF; BABY HUG Investigators.

Pediatrics. 2014 Oct;134(4):686-95. doi: 10.1542/peds.2014-0571. Epub 2014 Sep 1.

16.

Hydroxyurea and growth in young children with sickle cell disease.

Rana S, Houston PE, Wang WC, Iyer RV, Goldsmith J, Casella JF, Reed CK, Rogers ZR, Waclawiw MA, Thompson B; BABY HUG Investigators.

Pediatrics. 2014 Sep;134(3):465-72. doi: 10.1542/peds.2014-0917. Erratum in: Pediatrics. 2015 Sep;136(3):584.

17.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

18.

Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.

King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR.

Am J Hematol. 2014 Oct;89(10):E188-92. doi: 10.1002/ajh.23805. Epub 2014 Aug 4.

19.

Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.

Burnett AL, Anele UA, Trueheart IN, Strouse JJ, Casella JF.

Am J Med. 2014 Jul;127(7):664-8. doi: 10.1016/j.amjmed.2014.03.019. Epub 2014 Mar 25.

20.

Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN, Kwiatkowski JL, Roach ES, Kirkham FJ, Casella JF, DeBaun MR.

J Pediatr. 2014 May;164(5):1175-1180.e1. doi: 10.1016/j.jpeds.2014.01.001. Epub 2014 Feb 13.

21.

Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Sadreameli SC, Reller ME, Bundy DG, Casella JF, Strouse JJ.

Pediatr Blood Cancer. 2014 May;61(5):875-8. doi: 10.1002/pbc.24887. Epub 2014 Jan 31.

22.

Parent education and biologic factors influence on cognition in sickle cell anemia.

King AA, Strouse JJ, Rodeghier MJ, Compas BE, Casella JF, McKinstry RC, Noetzel MJ, Quinn CT, Ichord R, Dowling MM, Miller JP, Debaun MR.

Am J Hematol. 2014 Feb;89(2):162-7. doi: 10.1002/ajh.23604.

23.

Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.

Bhatnagar P, Barron-Casella E, Bean CJ, Milton JN, Baldwin CT, Steinberg MH, Debaun M, Casella JF, Arking DE.

PLoS One. 2013 Sep 13;8(9):e74193. doi: 10.1371/journal.pone.0074193. eCollection 2013.

24.

Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia.

Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD; BABY HUG Investigators.

Pediatrics. 2013 Oct;132(4):677-83. doi: 10.1542/peds.2013-0333. Epub 2013 Sep 2.

25.

Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.

Bean CJ, Boulet SL, Yang G, Payne AB, Ghaji N, Pyle ME, Hooper WC, Bhatnagar P, Keefer J, Barron-Casella EA, Casella JF, Debaun MR.

Br J Haematol. 2013 Oct;163(2):268-76. doi: 10.1111/bjh.12507. Epub 2013 Aug 16.

26.

Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.

Savage WJ, Reddoch S, Wolfe J, Casella JF.

J Pediatr Hematol Oncol. 2013 Aug;35(6):434-6. doi: 10.1097/MPH.0b013e31829d470d.

27.

Validation of the sickle cell disease pain burden interview-youth.

Zempsky WT, O'Hara EA, Santanelli JP, Palermo TM, New T, Smith-Whitley K, Casella JF.

J Pain. 2013 Sep;14(9):975-82. doi: 10.1016/j.jpain.2013.03.007. Epub 2013 May 20.

28.

Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia.

Bhatnagar P, Keefer JR, Casella JF, Barron-Casella EA, Bean CJ, Hooper CW, Payne AB, Arking DE, Debaun MR.

Pediatr Blood Cancer. 2013 Oct;60(10):E125-7. doi: 10.1002/pbc.24588. Epub 2013 May 15.

29.

Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia.

Faulcon LM, Fu Z, Dulloor P, Barron-Casella E, Savage W, Jennings JM, Van Eyk JE, Debaun M, Casella JF, Everett A.

Br J Haematol. 2013 Aug;162(3):421-4. doi: 10.1111/bjh.12374. Epub 2013 May 14. No abstract available.

30.

Daily changes in pain, mood and physical function in children hospitalized for sickle cell disease pain.

Zempsky WT, Palermo TM, Corsi JM, Lewandowski AS, Zhou C, Casella JF.

Pain Res Manag. 2013 Jan-Feb;18(1):33-8.

31.

Developmental function in toddlers with sickle cell anemia.

Armstrong FD, Elkin TD, Brown RC, Glass P, Rana S, Casella JF, Kalpatthi RV, Pavlakis S, Mi Z, Wang WC; Baby Hug Investigators.

Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.

32.

High rates of recurrent biliary tract obstruction in children with sickle cell disease.

Amoako MO, Casella JF, Strouse JJ.

Pediatr Blood Cancer. 2013 Apr;60(4):650-2. doi: 10.1002/pbc.24413. Epub 2012 Dec 19.

33.

Acute silent cerebral ischemic events in children with sickle cell anemia.

Quinn CT, McKinstry RC, Dowling MM, Ball WS, Kraut MA, Casella JF, Dlamini N, Ichord RN, Jordan LC, Kirkham FJ, Noetzel MJ, Roach ES, Strouse JJ, Kwiatkowski JL, Hirtz D, DeBaun MR.

JAMA Neurol. 2013 Jan;70(1):58-65. doi: 10.1001/jamaneurol.2013.576.

34.

Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

Bean CJ, Boulet SL, Ellingsen D, Pyle ME, Barron-Casella EA, Casella JF, Payne AB, Driggers J, Trau HA, Yang G, Jones K, Ofori-Acquah SF, Hooper WC, DeBaun MR.

Blood. 2012 Nov 1;120(18):3822-8. doi: 10.1182/blood-2011-06-361642. Epub 2012 Sep 10.

35.

Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.

Thangarajh M, Yang G, Fuchs D, Ponisio MR, McKinstry RC, Jaju A, Noetzel MJ, Casella JF, Barron-Casella E, Hooper WC, Boulet SL, Bean CJ, Pyle ME, Payne AB, Driggers J, Trau HA, Vendt BA, Rodeghier M, DeBaun MR.

Br J Haematol. 2012 Nov;159(3):352-9. doi: 10.1111/bjh.12034. Epub 2012 Sep 7.

36.

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.

Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, Garrett M, Hooper WC, Bean CJ, Debaun MR, Arking DE, Bhatnagar P, Casella JF, Keefer JR, Barron-Casella E, Gordeuk V, Kato GJ, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Hoppe C, Gladwin MT, Zhang Y, Steinberg MH.

Blood. 2012 Aug 30;120(9):1961-2. doi: 10.1182/blood-2012-06-432849. No abstract available.

37.

A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

Milton JN, Sebastiani P, Solovieff N, Hartley SW, Bhatnagar P, Arking DE, Dworkis DA, Casella JF, Barron-Casella E, Bean CJ, Hooper WC, DeBaun MR, Garrett ME, Soldano K, Telen MJ, Ashley-Koch A, Gladwin MT, Baldwin CT, Steinberg MH, Klings ES.

PLoS One. 2012;7(4):e34741. doi: 10.1371/journal.pone.0034741. Epub 2012 Apr 27.

38.

Ambulatory care connections of Medicaid-insured children with sickle cell disease.

Bundy DG, Muschelli J, Clemens GD, Strouse JJ, Thompson RE, Casella JF, Miller MR.

Pediatr Blood Cancer. 2012 Nov;59(5):888-94. doi: 10.1002/pbc.24129. Epub 2012 Mar 15.

PMID:
22422739
39.

Prospects for primary stroke prevention in children with sickle cell anaemia.

Jordan LC, Casella JF, DeBaun MR.

Br J Haematol. 2012 Apr;157(1):14-25. doi: 10.1111/j.1365-2141.2011.09005.x. Epub 2012 Jan 9. Review.

40.

Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.

Lebensburger JD, Miller ST, Howard TH, Casella JF, Brown RC, Lu M, Iyer RV, Sarnaik S, Rogers ZR, Wang WC; BABY HUG Investigators.

Pediatr Blood Cancer. 2012 Oct;59(4):675-8. doi: 10.1002/pbc.24037. Epub 2011 Dec 20.

41.

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF.

Blood. 2012 Apr 19;119(16):3684-90. doi: 10.1182/blood-2011-05-349621. Epub 2011 Nov 17.

42.

Urgency of emergency department visits by children with sickle cell disease: a comparison of 3 chronic conditions.

Bundy DG, Strouse JJ, Casella JF, Miller MR.

Acad Pediatr. 2011 Jul-Aug;11(4):333-41. doi: 10.1016/j.acap.2011.04.006.

PMID:
21764017
43.

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW; BABY HUG investigators.

Lancet. 2011 May 14;377(9778):1663-72. doi: 10.1016/S0140-6736(11)60355-3.

44.

Plasma glial fibrillary acidic protein levels in children with sickle cell disease.

Savage WJ, Barron-Casella E, Fu Z, Dulloor P, Williams L, Crain BJ, White DA, Jennings JM, Van Eyk JE, Debaun MR, Everett A, Casella JF.

Am J Hematol. 2011 May;86(5):427-9. doi: 10.1002/ajh.21995.

45.

Decision modeling of disagreements: pediatric hematologists' management of idiopathic thrombocytopenic purpura.

Lehmann HP, Dambita N, Buchanan GR, Casella JF; ITP Decision Group of the TMH Pediatric Subcommittee.

Med Decis Making. 2011 Nov-Dec;31(6):805-15. doi: 10.1177/0272989X11400417. Epub 2011 Mar 14.

PMID:
21402794
46.

Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity.

An P, Barron-Casella EA, Strunk RC, Hamilton RG, Casella JF, DeBaun MR.

J Allergy Clin Immunol. 2011 Jun;127(6):1440-6. doi: 10.1016/j.jaci.2010.12.1114. Epub 2011 Mar 9.

47.

Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.

Gladwin MT, Kato GJ, Weiner D, Onyekwere OC, Dampier C, Hsu L, Hagar RW, Howard T, Nuss R, Okam MM, Tremonti CK, Berman B, Villella A, Krishnamurti L, Lanzkron S, Castro O, Gordeuk VR, Coles WA, Peters-Lawrence M, Nichols J, Hall MK, Hildesheim M, Blackwelder WC, Baldassarre J, Casella JF; DeNOVO Investigators.

JAMA. 2011 Mar 2;305(9):893-902. doi: 10.1001/jama.2011.235.

48.

Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.

Bhatnagar P, Purvis S, Barron-Casella E, DeBaun MR, Casella JF, Arking DE, Keefer JR.

J Hum Genet. 2011 Apr;56(4):316-23. doi: 10.1038/jhg.2011.12. Epub 2011 Feb 17.

49.

Hemoglobin depletion from plasma: considerations for proteomic discovery in sickle cell disease and other hemolytic processes.

Williams LM, Fu Z, Dulloor P, Yen T, Barron-Casella E, Savage W, Van Eyk JE, Casella JF, Everett A.

Proteomics Clin Appl. 2010 Dec;4(12):926-30.

50.

Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke.

Savage WJ, Everett AD, Casella JF.

Acta Haematol. 2011;125(3):103-6. doi: 10.1159/000321791. Epub 2010 Nov 24.

Supplemental Content

Loading ...
Support Center